Unlike many other types of cancers, prostate cancer has numerous treatment options. There is no one definitive course of treatment.
Memorial Hermann Cancer Centers bring together cancer-focused specialists together in one location to talk with patients directly and answer any questions. The team includes:
- medical oncologists
- nurse navigators (cancer nurse specialists)
It also allows cancer specialists to work together not only in treatment planning but also in delivery. Oftentimes, a combination of therapies is the best option for patients.
Memorial Hermann offers a broad range of treatment options for prostate cancer, including:
Prostate removal surgery
Prostate removal surgery is available with both traditional and robotic-assisted surgery methods. Robotic surgery is a minimally invasive approach in which surgeons use advanced technology to perform precise, nerve-sparing surgery. Learn more.
Advanced radiation therapies
Memorial Hermann offers advanced radiation therapies, including IMRT and seed implant brachytherapy, which dramatically reduce damage to surrounding healthy tissue.
Intensity-modulated radiation therapy (IMRT)
IMRT is a state-of-the-art external beam radiation system that precisely shapes radiation beams to the shape of the tumor. Learn more.
The treatment involves implanting tiny radioactive seeds that emit low levels of radiation over a few months directly to the prostate. Learn more.
Clinical trials of new prostate cancer treatments available through Memorial Hermann's collaboration with Texas Oncology. Some trials involve chemotherapy, which is not a typical treatment for prostate cancer. These trials provide patients the option of participating in promising cancer therapies not yet available to the public.
Search Memorial Hermann research and clinical trials.
Prostate Cancer Tumor Board
Memorial Hermann Cancer Centers also have a prostate cancer tumor board, which is made up of urologists, radiation oncologists, radiologists, medical oncologists, pathologists and other specialists. The board meets weekly to discuss and confirm the treatment plan for challenging cancer cases. Patients can refer themselves for this multidisciplinary review. This can be especially useful to those seeking a second opinion.